VanEck Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.25M | Sell |
83,074
-2,991
| -3% | -$261K | 0.01% | 589 |
|
|
2025
Q1 | $5.88M | Buy |
86,065
+252
| +0.3% | +$17.2K | 0.01% | 650 |
|
|
2024
Q4 | $6.67M | Buy |
85,813
+65,622
| +325% | +$5.1M | 0.01% | 588 |
|
|
2024
Q3 | $1.46M | Buy |
20,191
+2,475
| +14% | +$179K | ﹤0.01% | 951 |
|
|
2024
Q2 | $2.01M | Buy |
17,716
+1,274
| +8% | +$144K | ﹤0.01% | 882 |
|
|
2024
Q1 | $2.28M | Sell |
16,442
-1,517
| -8% | -$210K | ﹤0.01% | 825 |
|
|
2023
Q4 | $2.23M | Sell |
17,959
-2,674
| -13% | -$332K | ﹤0.01% | 776 |
|
|
2023
Q3 | $1.93M | Buy |
20,633
+1,877
| +10% | +$175K | ﹤0.01% | 754 |
|
|
2023
Q2 | $2.41M | Sell |
18,756
-1,199
| -6% | -$154K | 0.01% | 680 |
|
|
2023
Q1 | $2.32M | Buy |
19,955
+9,326
| +88% | +$1.08M | 0.01% | 675 |
|
|
2022
Q4 | $1.2M | Buy |
10,629
+4,385
| +70% | +$497K | ﹤0.01% | 769 |
|
|
2022
Q3 | $503K | Buy |
+6,244
| New | +$503K | ﹤0.01% | 889 |
|
|
2022
Q1 | – | Sell |
-1,232
| Closed | -$165K | – | 1380 |
|
|
2021
Q4 | $165K | Buy |
+1,232
| New | +$165K | ﹤0.01% | 1144 |
|
|
2021
Q1 | – | Sell |
-5,284
| Closed | -$488K | – | 1229 |
|
|
2020
Q4 | $488K | Buy |
5,284
+3,524
| +200% | +$325K | ﹤0.01% | 778 |
|
|
2020
Q3 | $181K | Buy |
+1,760
| New | +$181K | ﹤0.01% | 829 |
|